| 09 Feb, 07:39 pm | — | … | Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 09 Feb, 07:38 pm | — | … | Supriya Lifescience Limited has informed the Exchange regarding Change in Director(s) of the company. | nse |
| 09 Feb, 07:28 pm | — | … | Supriya Lifescience Ltd - 543434 - Financial Result Quarter Ended On December 31, 2025 | bse |
| 09 Feb, 07:25 pm | — | … | Supriya Lifescience Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025. | nse |
| 09 Feb, 07:17 pm | — | … | Supriya Lifescience Limited has informed the Exchange regarding Board meeting held on February 09, 2026. | nse |
| 04 Feb, 12:45 pm | — | … | Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that an earnings call will be held on Tuesday, February 10, 2026, at 11.00 A.M. IST to discuss operational and financial performance of the Company for the quarter and nine months ended December 31, 2025. The invite giving requisite details including the pre-registration link and dial-in details is enclosed herewith. The investor presentation shall be shared with the Excha | nse |
| 03 Feb, 12:06 pm | — | … | The Exchange had sought clarification from Supriya Lifescience Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1.Segment details not submitted The response of the Company is enclosed. | nse |
| 02 Feb, 05:37 pm | — | … | Supriya Lifescience Ltd - 543434 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2025. | bse |
| 13 Jan, 12:09 pm | — | … | The Exchange has sought clarification from Supriya Lifescience Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited. | nse |
| 30 Dec, 03:40 pm | — | … | Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Credit Rating | bse |
| 30 Dec, 03:39 pm | — | … | Supriya Lifescience Limited has informed the Exchange about Credit Rating | nse |
| 18 Nov, 10:48 am | — | … | Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 18 Nov, 10:47 am | — | … | Supriya Lifescience Limited has informed the Exchange about Transcript | nse |
| 13 Nov, 05:48 pm | — | … | Supriya Lifescience Limited has informed the Exchange about Copy of Newspaper Publication for the Unaudited Financial Results for the Quarter and Half Year ended September 30, 2025 is enclosed herewith. | nse |
| 13 Nov, 05:20 pm | — | … | Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 13 Nov, 05:18 pm | — | … | Supriya Lifescience Limited has informed the Exchange about Link of Recording of the Earnings Call for the quarter and half year ended September 30, 2025 is enclosed herewith. | nse |
| 13 Nov, 02:42 pm | — | … | Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 13 Nov, 02:41 pm | — | … | Supriya Lifescience Limited has informed the Exchange regarding a press release dated November 13, 2025, titled "Press Release for the Unaudited Financial Results for the Quarter and Half Year ended September 30, 2025". | nse |
| 12 Nov, 06:02 pm | — | … | Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 12 Nov, 06:01 pm | — | … | Supriya Lifescience Limited has informed the Exchange about Investor Presentation | nse |
| 12 Nov, 05:25 pm | — | … | Supriya Lifescience Ltd - 543434 - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025. | bse |
| 12 Nov, 05:25 pm | — | … | Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its Meeting held on Wednesday, November 12, 2025, inter-alia considered and approved the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2025. A copy of the same is enclosed along with the Limited Review Report of the Statutory Auditors thereon in terms of SEBI (LODR) Regulations, 20 | nse |
| 12 Nov, 05:10 pm | — | … | Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its Meeting held on Wednesday, November 12, 2025, inter-alia considered and approved the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2025. A copy of the same is enclosed along with the Limited Review Report of the Statutory Auditors thereon in terms of SEBI (LODR) Regulations, 20 | nse |
| 09 Nov, 11:15 pm | — | … | Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that an earnings call will be held on Thursday, November 13, 2025 at 11.00 A.M. IST to discuss operational and financial performance of the Company for the quarter and half year ended September 30, 2025. The invite giving requisite details including the pre-registration link and dial-in details is enclosed herewith. The investor presentation shall be shared with the Exchan | nse |
| 05 Nov, 08:31 pm | — | … | Supriya Lifescience Ltd - 543434 - Board Meeting Intimation for To Consider And Approve Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2025 | bse |
| 01 Oct, 12:47 pm | — | … | Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 01 Oct, 12:45 pm | — | … | Supriya Lifescience Limited has informed the Exchange regarding a press release dated October 01, 2025, titled "Completion of WHO GMP Audit at Ambernath facility of the Company". | nse |
| 17 Sept, 04:30 pm | — | … | Details of Analyst/ Institutional Investor Meeting scheduled on September 23, 2025 in which the Company shall participate are attached. | nse |
| 11 Sept, 05:46 pm | — | … | The Exchange had sought clarification from Supriya Lifescience Limited for the quarter ended 30-Jun-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Segment details not submitted The response of the Company is enclosed. | nse |
| 11 Sept, 04:21 pm | — | … | The Exchange has sought clarification from Supriya Lifescience Limited for the quarter ended 30-Jun-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited. | nse |
| 02 Sept, 02:25 pm | — | … | Supriya Lifescience Ltd - 543434 - Intimation Under Regulation 30 Regarding Letter Dispatched To The Shareholders Of The Company Providing Weblink | bse |
| 02 Sept, 02:24 pm | — | … | Enclosed herewith is the Letter under Regulation 36 (1) of SEBI (LODR)Regulations, 2015, dispatched by the Company to the Shareholders whose email ids are not registered with the Company / Depositories/ RTA. | nse |
| 01 Sept, 07:17 pm | — | … | Supriya Lifescience Ltd - 543434 - Reg. 34 (1) Annual Report. | bse |
| 01 Sept, 07:02 pm | — | … | Supriya Lifescience Limited has informed the Exchange regarding Notice of 17th Annual General Meeting to be held on September 24, 2025 at 3.00 pm. through Video Conferencing (VC)/ Other Audio Video Means (OAVM). | nse |